Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears sponsor, health industry and advocacy groups on DNA/neurodata privacy bill
Summary
Senate Bill 163 drew testimony from the sponsor, pharmaceutical manufacturers and advocacy groups. The bill would create rules for consent, storage and cross‑border transfer of genetic and neurodata; the sponsor signaled amendments and asked for additional drafting time.
Senator Daniel Zolomikov, sponsor of Senate Bill 163, told the House Energy, Technology and Government Affairs Committee his bill would give individuals ownership rights over genetic data and emerging neural data and impose consent, deletion and storage rules for how that data is used.
“Your data is your data,” the sponsor said in a lengthy opening, arguing that DNA and neurotechnology data require distinct protections and asserting that the bill would allow Montanans to control whether pooled samples are retained and used. The sponsor described provisions that require “expressed and informed written consent” and said…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
